Haleon (HLN) Cash & Current Investments (2021 - 2026)
Haleon's (HLN) quarterly Cash & Current Investments came in at $963.3 million in Q2 2026, down 48.72% on a QoQ basis from $1.9 billion in Q4 2025.
Haleon (HLN) Cash & Current Investments (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Cash & Current Investments data on file, last reported at $963.3 million in Q2 2026.
- Quarterly Cash & Current Investments changed N/A year-over-year to $963.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $963.3 million (changed N/A YoY) and the FY2025 annual result came in at $1.9 billion, down 38.7% from the prior year.
- Cash & Current Investments eased to $963.3 million in Q2 2026, from $1.9 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $3.1 billion in Q4 2024 to a low of $381.7 million in Q2 2023.
- A 5-year average of $1.4 billion and a median of $1.1 billion in 2023 frame the typical range for Cash & Current Investments.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 79.52% — and 2024, when it surged 130.67%.
- Tracing HLN's Cash & Current Investments over 5 years: stood at $860.9 million in 2022, then jumped by 53.82% to $1.3 billion in 2023, then surged by 130.67% to $3.1 billion in 2024, then tumbled by 38.51% to $1.9 billion in 2025, then slumped by 48.72% to $963.3 million in 2026.
- The last three Cash & Current Investments figures came in at $963.3 million (Q2 2026), $1.9 billion (Q4 2025), and $3.1 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 164.00 Mn |
| 10 | Alkermes | 8.19 Bn | 7.53 Bn | 397.90 Mn | 656.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 963.33 Mn |
| Dec 31, 2025 | 1.88 Bn |
| Dec 31, 2024 | 3.05 Bn |
| Jun 30, 2024 | 541.49 Mn |
| Dec 31, 2023 | 1.32 Bn |
| Jun 30, 2023 | 381.67 Mn |
| Dec 31, 2022 | 860.93 Mn |
| Jun 30, 2022 | 1.86 Bn |
| Dec 31, 2021 | 564.82 Mn |